Lyra Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Lyra Therapeutics

09/08/2021 22:43

* Lyra Therapeutics Inc  LYRA.OQ  reported a quarterly adjusted
loss of 85 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 59 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Lyra Therapeutics Inc's reported EPS for the quarter was a
loss of 85 cents​.
* The mean earnings estimate of analysts had fallen by
about 13.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Lyra Therapeutics Inc shares had fallen by 13.2% this
quarter and lost 38.9% so far this year.
* The company reported a quarterly loss of $11.04 million.
* Wall Street's median 12-month price target for Lyra
Therapeutics Inc is $26.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 09:42 p.m.  ​All
figures in US dollars unless otherwise stated